LOS ANGELES, Feb. 20, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative ...
ACELYRIN, Inc., a Los Angeles area-based, late-stage clinical biopharma, with additional operations in the San Francisco Bay area, has announced it is acquiring privately held ValenzaBio – which ...
After hours: February 20 at 6:40:00 PM EST ...
Dec. 11, 2024 at 4:48 p.m. ET on TipRanks.com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback